Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Blenrep’s Comeback Continues As England Becomes First To Fund Drug
Jun 13 2025
•
By
Eliza Slawther
Blenrep was recently approved as a second-line treatment for multiple myeloma in combination with other drugs
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Product Reviews